Mutational and biochemical analysis of dopamine in dystonia: Evidence for decreased dopamine D2 receptor inhibition

Molecular Neurobiology

Volumn 16, Issue 2, 1998, Pages 135-147

  Todd, Richard D ^a   Perlmutter, Joel S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; Dopamine receptors; Dystonia; GTP cyclohydroxylase; Putamen; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BASAL GANGLION; DOPAMINE METABOLISM; DOPAMINERGIC TRANSMISSION; DYSTONIA; GENE MUTATION; GENETIC LINKAGE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PUTAMEN;

EID: 0031829426     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740641     Document Type: Article

References (67)

1. 3 dopamine receptor gene is associated with hyperactivity in mice. Proc. Natl. Acad. Sci. USA 93, 1945-1949.
2. Albin R. L., Young A. B., and Penny J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366-375.
3. Alexander G. and Crutcher M. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266-271.
4. Ashizawa T., Patten B., and Jankovic J. (1980) Meige's syndrome. South. Med. J. 73, 863-866.
5. 2 receptors. Nature 377, 424-428.
6. Ballard P. A., Tetrud J. W., and Langston J. W. (1985) Permanent human parkinsonism due to 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35, 949-956.
7. Bankiewicz K., Oldfield E., Chiueh C., Doppman J., Jacobowitz D., and Kopin I. (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Life Sci. 39, 7-16.
8. Beales M., Lorden J. F., Walz E., and Oltmans G. A. (1990) Quantitative autoradiography reveals selective changes in cerebellar GABA receptors of the rat mutant dystonic. J. Neurosci. 10, 1874-1885.
9. Bhatia K. and Marsden C. D. (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man. Brain 117, 859-876.
10. Brashear A., Farlow M. R., Butler I. J., Kasarskis E. J., and Dobyns W. B. (1996) Variable phenotype of rapid-onset dystonia-parkinsonism. Mov. Disord. 11, 151-156.
11. Bressman S. G., de Leon D., Kramer P. L., Ozelius L. J., Brin M. F., Greene P. E., Fahn S., Breakefield X. O., and Risch N. J. (1994) Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation. Ann. Neurol. 36, 771-777.
12. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-1-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
13. Ceballos-Baumann A. O., Passingham R. E., Warner T., Playford E. D., Marsden C. D., and Brooks D. J. (1995) Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia. Ann. Neurol. 37, 363-372.
14. Civelli O., Bunzow J. R., and Grandy D. K. (1993) Molecular diversity of the dopamine receptors. Ann. Rev. Pharmacol. Toxicol. 33, 281-307.
15. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281-285.
16. Drago J., Gerfen C. R., Lachowicz J. E., Steiner H., Hollon T. R., Love P. E., Ooi G. T., Grinberg A., Lee E. J., Huang S. P. (1994) Altered striatal function in a mutant mouse lacking DIA dopamine receptors. Proc. Natl. Acad. Sci. USA 91, 12,564-12,568.
17. Garver D., Davis J., Dekirmenjian H., et al. (1976) Dystonic reactions following neuroleptics: Time course and proposed mechanisms. Psychopharmacologia 47, 199-201.
18. Gasser T., Bove C. M., Ozelius L. J., Hallett M., Charness M. E., Hochberg F. H., and Breakefield X. O. (1996) Haplotype analysis at the DYT1 locus in Ashkenazi Jewish patients with occupational hand dystonia. Mov. Disord. 11, 163-166.
19. Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15, 133-139.
20. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432.
21. Gerfen C. R., McGintry J. F., and Young W. S. (1991) Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis. J. Neurosci. 11, 1016-1031.
22. Giros B., Jaber M., Jones S. R., Wightman R. M., and Caron M. D. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606-612.
23. Guttman M., Fibiger H. C., Jakubovic A., and Calne D. G. (1990) Intracarotid 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism. J. Neurochem. 54, 1329-1334.
24. Haberhausen G., Schmitt I., Kohler A., Peters U., Rider S., Chelly J., Terwilliger J. D., Monaco A. P., and Muller U. (1995) Assignment of the dystonia-parkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1. Am. J. Hum. Genet. 57, 644-650.
25. Hornykiewicz O., Kish S., Becker L., Farley I., and Shannak K. (1986) Brain neurotransmitters in dystonia musculorum deformans. N. Engl. J. Med. 315, 347-353.
26. Jinnah H. A., Wojcik B. E., Hunt M., Narang N., Lee K. Y., Goldstein M., Wamsley J. K., Langlais P. J., and Friedmann T. (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J. Neurosci. 14, 1164-1175.
27. 2 receptor density. Brain Res. 382, 360-364.
28. 2 dopamine receptor synergy in striatum: Effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66, 903-913.
29. Knappskog P. M., Flatmark T., Mallet J., Lhdecke B., and Bartholom J. K. (1995) Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 1209-1212.
30. Kolbe H., Clow A., Jenner P., and Marsden C. D. (1981) Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors. Neurology 31, 434-439.
31. Lang A. E. (1995) Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome. Mov. Disord. 10, 489-495.
32. 4 (valine194glycine), is insensitive to dopamine and clozapine - Report of a homozygous individual. Am. J. Med. Genet. 6, 277-282.
33. Lobos E. A. and Todd R. D. (1997) Cladistic analysis of disease association with tyrosine hydroxylase: application to manic-depressive disease and alcoholism. Am. J. Med. Genet. (Neuropsychiatric Genetics) 74, 289-295.
34. Lorden J. F., McKeon T. W., Baker H. J., Cox N., and Walkley, S. U. (1984) Characterization of the rat mutant dystonic (dt): a new animal model of dystonia musculorum deformans. J. Neurosci. 4, 1925-1932.
35. Lorden J. F., Oltmans G. A., Stratton S., and Mays L. E. (1988) Neuropharmacological correlates of the motor syndrome of the genetically dystonic (dt) rat. Adv. Neurol. 50, pp. 277-297.
36. Löscher W., Annies R., and Richter A. (1994) Marked regional disturbances in brain metabolism of monoaminergic neurotransmitters in the genetically dystonic hamster. Brain Res. 658, 199-208.
37. Löscher W., Fisher J. E., Jr., Schmidt D., Fredow G., Hńack D., and Iturrian W. B. (1989) The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia? Mov. Disord. 4, 219-232.
38. Ludecke B., Knappskog P. M., Clayton P. T., Surtees R. A. H., Clelland J. D., Heales S. J. R., Brand M. P., Bartholome K., and Flatmark T. (1996) Recessively inherited L-dopa-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 5, 1023-1028.
39. Micheli S., Fernández-Pardal M., Quesada P., Brannan T., and Obeso J. A. (1994) Variable onset of adult inherited focal dystonia: a problem for genetic studies. Mov. Disord. 9, 64-68.
40. Mink J. W. (1996) The basal ganglia: focused selection and inhibition of competing motor programs. Prog. Neurobiol. 50, 381-425.
41. Mink J. W. and Thach W. T. (1993) Basal ganglia intrinsic circuits and their role in behavior. Curr. Opin. Neurobiol. 3, 950-957.
42. Mitchell I., Luguin R., Boyce S., Clarke C., Robertson R., Sambrook M., and Crossman A. (1990) Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystonia. Mov. Disord. 5, 49-54.
43. Nagatsu T. and Ichinose H. (1996) GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism. Neurochem. Res. 21, 245-250.
44. 2 receptor binding in the genetically dystonic hamster. Neuroscience 71, 927-936.
45. Nöthen N. M., Cichon S., Hemmer S., Hebebrand J., Ramschmidt H., Lehmkuhl G., Poustka F., Schmidt M., Catalano M., and Fimmers R. (1994) Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Hum. Mol. Genet. 3, 2207-2212.
46. 4 receptors. J. Pharm. Exp. Ther. 277, 186-192.
47. Ozelius L. J., Kramer P. L., de Leon D., Risch N., Bressman S. B., Schuback D. E., Brin M. F., Kwiatkowski D. J., Burke R. E., Gusella J. F., Fahn S., and Breakefield X. O. (1992) Strong allelic association between the torsion dystonia gene (DYTI) and loci on chromosome 9q34 in Ashkenazi Jews. Am. J. Hum. Genet. 50, 619-628.
48. Ozelius L., Kramer P. L., Moskowitz C. B., Kwiatkowski D. J., Brin M. F., Bressman S. B., Schuback D. E., Falk C. T., Risch N., de Leon D., Burke R. E., Haines J., Gusella J. F., Fahn S., and Breakefield X. O. (1989) Human gene for torsion dystonia located on chromosome 9q32-q34. Neuron 2, 1427-1434.
49. Ozelius L. J., Hewett J. W., Page C. G., et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nature Genet. 17, 40-48.
50. Palombo E., Porrino L. J., Bankiewicz K. S., Crane A. M., Sokoloff L., and Kopin I. J. (1990) Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J. Neurosci. 10, 860-869.
51. 18F]spiperone binding in putamen in idiopathic focal dystonia. J. Neurosci. 17, 843-850.
52. Perlmutter J. S., Tempel L. W., and Lieh L. (1993). A new animal model of dystonia. Soc. Neurosci. Abstr 19, 1052.
53. Perlmutter J. S., Tempel L. W., Black K. J., Parkinson D., and Todd R. D. (1997) MPTP induced dystonia and parkinsonism: clues to the pathophysiology of dystonia. Neurology (in press).
54. 18F]dopa uptake in familial idiopathic dystonia. Brain 116, 1191-1199.
55. Rupniak N., Jenner P., and Marsden C. D. (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88, 403-419.
56. Stojanović M., Cvetković D., and Kostić V. S. (1995) A genetic study of idiopathic focal dystonias. J. Neurol. 242, 508-511.
57. Strange P. G. (1993) Dopamine receptors in the basal ganglia: Relevance to Parkinson's disease. Mov. Disord. 8, 263-270.
58. Surmeier D. J., Reiner A., Levine M. S., and Ariano M. A. (1993) Are neostriatal dopamine receptors co-localized? Trends Neusoci. 16, 299-305.
59. 3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475-479.
60. Tempel L. W. and Perlmutter J. S. (1990) Abnormal vibration-induced cerebral blood flow responses in idiopathic dystonia. Brain 113, 691-707.
61. Tempel L. W. and Perlmutter J. S. (1993) Abnormal cortical responses in patients with writer's cramp. Neurology 43, 2252-2257.
62. Thomas S. A. and Palmiter R. D. (1997) Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline. Nature 387, 94-97.
63. 3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine (MPTP) denervation in baboons. J. Neurosci. 16, 7776-7782.
64. Waddy H., Fletcher N., Harding A., and Marsden C. (1991) A genetic study of idiopathic focal dystonias. Ann. Neurol. 29, 320-324.
65. Williams A. C. (1995) Dopamine, dystonia, and the deficient co-factor. Lancet 345, 1130.
66. Zhou Q. Y. and Palmiter R. D. (1995) Dopamine-deficient mice are severely hypoactive, adipsic and aphagic. Cell 83, 1197-1209.
67. Zhou Q. Y., Quaife C. J., and Palmiter R. D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 374, 640-643.